Acute Investment Advisory’s CSX Corp CSX Stock Holding History

Acute Investment Advisory’s Portfolio CSX Stock Details CSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,381	Closed	-$298K	–	16
2025 Q3	$298K	Hold	8,381	–	–	2.5%	12
2025 Q2	$273K	Hold	8,381	–	–	2.23%	15
2025 Q1	$247K	Hold	8,381	–	–	1.24%	15
2024 Q4	$270K	Hold	8,381	–	–	0.3%	17
2024 Q3	$289K	Sell	8,381 -2,956	-26%	-$100K	0.17%	14
2024 Q2	$379K	Hold	11,337	–	–	0.22%	10
2024 Q1	$420K	Hold	11,337	–	–	0.28%	6
2023 Q4	$393K	Hold	11,337	–	–	0.23%	11
2023 Q3	$349K	Hold	11,337	–	–	0.21%	11
2023 Q2	$387K	Hold	11,337	–	–	0.23%	12
2023 Q1	$339K	Hold	11,337	–	–	0.22%	11
2022 Q4	$351K	Hold	11,337	–	–	0.24%	15
2022 Q3	$302K	Hold	11,337	–	–	0.22%	25
2022 Q2	$329K	Hold	11,337	–	–	0.26%	26
2022 Q1	$425K	Hold	11,337	–	–	0.32%	33
2021 Q4	$426K	Buy	+11,337	New	+$400K	0.31%	40

Other funds holding CSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Acute Investment Advisory's CSX Position: Q4 2025 in Review

Acute Investment Advisory sold out of CSX Corp (CSX) in Q4 2025, closing a stake of 8,381 shares — an estimated $298K sold.

Acute Investment Advisory first reported a position in CSX in Q4 2021 and held it in 16 quarters. The position peaked at $426K in Q4 2021. 1,813 funds tracked by Wall St. Rank hold CSX as of Q4 2025.

Acute Investment Advisory reported no remaining CSX Corp position as of Q4 2025 after selling out during the quarter.
Acute Investment Advisory sold 8,381 CSX Corp shares in Q4 2025, an estimated $298K.
Acute Investment Advisory first reported a position in CSX Corp in Q4 2021 and held it in 16 quarters.
Acute Investment Advisory's CSX Corp position peaked at $426K in Q4 2021.
1,813 funds tracked by Wall St. Rank held CSX Corp as of Q4 2025.

Based on Acute Investment Advisory's 13F filing for Q4 2025, filed 27 Jan 2026.